Not Allowed For Sprue, BPOM Disallows the Circulation of Albothyl from Pharos

By : Ahmad Fadli Dan Aldo Bella Putra | Saturday, February 17 2018 - 16:00 IWST

BPOM melarang peredaran produk Albothy PT Pharos Indonesia
BPOM melarang peredaran produk Albothy PT Pharos Indonesia

INDUSTRY.co.id - Jakarta - Through a circular of the Food and Drug Supervisory Agency (BPOM), Thursday (15/2 /) it prohibits the circulation of Albothyl products. There are policresulent contents that can cause a person suffering from serious illness.

The product is rated to contain 36% concentrated policresulent concentrate which is not recommended for curing skin diseases to dental and gum problems.

Albothyl is an external drug used by dripping on the point of sick skin. In his statement BPOM states that policresulen is sold must be prescribed by a doctor.

Policresulen is a type of antiseptic that can overcome the skin. But generally to overcome the intimate area, such as genital warts, cervical inflammation, vaginal inflammation and other problems associated with vital organs.

Albothyl products have been produced by PT Pharos. According to the Manager of PT Pharos, Imawan explained that BPOM is actually just a sign for the public to be careful when using Albothyl when overcoming sprue.

"The use of this drug is only for the intimate area of ​​women more precisely because policresulen content can be used to treat any kind of skin diseases, except for cancer patients," Imawan said as reported.

Imawan explained, the company has not made withdrawal of Albothyl products.

"BPOM has sent a letter to PT Pharos and is being reviewed first," he continued.

Pharos pharmaceutical producers lately their products received a review from BPOM. One of the Viostin DSs found to contain pig DNA.

News Comment

Today's Industry

Collaboration and innovation is a common thread of various Business Twenty (B20) forums as an important part of G20 activities in 2022. (Foto: Liputan6.com)

Selasa, 21 Juni 2022 - 17:53 WIB

Inter Sectors Collaboration in Strengthening SMEs, Key for Post-Pandemic Recovery Acceleration

Indonesia owns an important role to support the world’s policy that prioritize various parties collaborations as the key to realize an inclusive world economy, included Small Middle Enterprises…

Collaboration and innovation is a common thread of various Business Twenty (B20) forums as an important part of G20 activities in 2022. (Foto: Liputan6.com)

Senin, 06 Juni 2022 - 21:35 WIB

Collaboration and Innovation, Key to support Inclusive Economy Growth

Collaboration and innovation is a common thread of various Business Twenty (B20) forums. This is an important part of G20 activities in 2022. That matters are also going to become a main key…

NORD-DuoDrive.jpg: The innovative and patented DuoDrive geared motor reaches outstanding system efficiency Image: NORD DRIVESYSTEMS

Selasa, 17 Mei 2022 - 14:00 WIB

NORD DRIVESYSTEMS at LogiMAT in Stuttgart From 31st May to 2nd June 2022 NORD will present innovative drive solutions for intralogistics

The specialist LogiMAT exhibition in Stuttgart offers as comprehensive overview of the intralogistics and process management market. As one of the market leaders for drive technology, NORD presents…

President Jokowi attends the meeting between ASEAN leaders and American entrepreneurs at Intercontinental the Willard Hotel, Washington DC, Thursday (05/12). Photo by: Laily Rachev

Selasa, 17 Mei 2022 - 13:00 WIB

President Jokowi Invites US CEOs to Boost Cooperation with Indonesia

President Joko “Jokowi” Widodo has invited company CEOs in the United States to boost cooperation with ASEAN countries, particularly Indonesia.

President Jokowi, President Biden, and ASEAN Leaders on a group photo prior to the dinner, at the White House, Washington D.C., Thursday (05/12)

Selasa, 17 Mei 2022 - 12:28 WIB

President Jokowi, ASEAN Leaders Attend Dinner Hosted by US President

President Joko “Jokowi” Widodo Thursday (05/12) attended a dinner with the leaders of ASEAN countries hosted by President of the United States Joe Biden at the White House, Washington D.C.